Allergic rhinitis is both common and burdensome. It reduces quality of life, school and work performance, and increases healthcare seeking. Furthermore, allergic rhinitis is increasingly recognized as an immunoglobulin E-mediated inflammatory condition that is strongly associated with asthma, with implications for both the development and the management of asthma.New treatments and new evidence have emerged in recent years, prompting the update of major clinical practice guidelines in North America and Europe. This program reviews current updates in the recommendations for management of allergic rhinitis and supports pharmacists in helping patients who are suffering from allergic rhinitis symptoms.
Allergic Rhinitis Update: Nose Ahead in Your Pharmacy – Canadian Council On Continuing Education In Pharmacy (CCCEP)
CAN-eng
$0
free
CCCEP
1
Respirology
1 Credits
Course Description
Course Details
Expiry Date: 2020-02-19
Professions: Pharmacy
Faculty
Paul Keith, MD, MSc, FRCPC
Betty Golightly, BSc. Pharm., R.Ph
Simon Lessard, B.Pharm, MBA, CRE, CTE
Accreditation
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP)
for 1 CEU.
CCCEP File Number: 1066-2019-2675-I-P
Learning Objective(s)
After completion of the program, the participant will be able to:
- Describe the allergic rhinitis burden and prevalence
- Initiate prescriptions or make recommendations to optimize management of allergic rhinitis in accordance with the most recent guideline updates
- Counsel patients on the proper administration of intranasal sprays